Patents by Inventor Kirstin Scherlach

Kirstin Scherlach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9522930
    Abstract: The present invention relates to novel Chartreusin analogues of formula (I), pharmaceutical compositions comprising the same and to their use for the treatment of cancer and other diseases.
    Type: Grant
    Filed: July 30, 2013
    Date of Patent: December 20, 2016
    Assignee: LEIBNIZ-INSTITUT FÜR NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE
    Inventors: Christian Hertweck, Hans-Martin Dahse, Nico Ueberschaar, Tom Bretschneider, Kirstin Scherlach, Mikko Metsae-Ketelae
  • Publication number: 20150210741
    Abstract: This invention concerns a novel compound termed jagaricin, jagaricin derivatives, pharmaceutical compositions comprising these compounds, a method for producing jagaricin, and the use of the novel compound as fungicide or antitumor agent.
    Type: Application
    Filed: August 22, 2013
    Publication date: July 30, 2015
    Inventors: Tom Bretschneider, Katharina Graupner, Christian Hertweck, Gerald Lackner, Kirstin Scherlach
  • Publication number: 20150197539
    Abstract: The present invention relates to novel Chartreusin analogues of formula (I), pharmaceutical compositions comprising the same and to their use for the treatment of cancer and other diseases.
    Type: Application
    Filed: July 30, 2013
    Publication date: July 16, 2015
    Inventors: Christian Hertweck, Hans-Martin Dahse, Nico Ueberschaar, Tom Bretschneider, Kirstin Scherlach, Mikko Metsae-Ketelae
  • Patent number: 9062077
    Abstract: This invention relates to the field of biologically active compounds and specifically to phaeofungins, of the general formula (I) or a pharmacologically acceptable salt, solvate, hydrate or a pharmacologically acceptable formulation thereof, pharmaceutical compositions comprising these compounds, methods for the production of the phaeofungins and their use as fungicide, antibiotic as well as antitumor agent.
    Type: Grant
    Filed: June 15, 2012
    Date of Patent: June 23, 2015
    Assignee: Leibniz-Institut fuer Naturstoff-Forschung und Infektionsbiologie E.V. Hans-Knoell-Institute (HKI)
    Inventors: Axel Brakhage, Hans-Martin Dahse, Christian Hertweck, Hans-Wilhelm Nuetzmann, Kirstin Scherlach
  • Publication number: 20140315896
    Abstract: This invention relates to the field of biologically active compounds and specifically to phaeofungins, of the general formula (I) or a pharmacologically acceptable salt, solvate, hydrate or a pharmacologically acceptable formulation thereof, pharmaceutical compositions comprising these compounds, methods for the production of the phaeofungins and their use as fungicide, antibiotic as well as antitumor agent.
    Type: Application
    Filed: June 15, 2012
    Publication date: October 23, 2014
    Applicant: Leibniz-Institut fuer Naturstoff-Forschung und Infektionsbiologie E.V. Hans-Knoell-Institut (HKI)
    Inventors: Axel Brakhage, Hans-Martin Dahse, Christian Hertweck, Hans-Wilhelm Nuetzmann, Kirstin Scherlach
  • Publication number: 20090233976
    Abstract: The invention concerns four novel secondary metabolites of the Burkholderia rhizoxina endosymbiont, a method for isolating said compounds from cultures of the bacteria and the use of said substances. The invention aims at providing novel rhizoxin derivatives with an antimitotic effect. Therefore, the following substances 1-4 are isolated, said substances exhibiting potential antifungal, cytotoxic and antiproliferative properties.
    Type: Application
    Filed: September 25, 2006
    Publication date: September 17, 2009
    Inventors: Kirstin Scherlach, Laila Partida-Martinez, Christian Hertweck